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Abstract
Background: Blood pressure (BP) variability has been associated with cardiovascular outcomes, but there is no
consensus about the more effective method to measure it by ambulatory blood pressure monitoring (ABPM). We
evaluated the association between three different methods to estimate BP variability by ABPM and the ankle
brachial index (ABI).
Methods and Results: In a cross-sectional study of patients with hypertension, BP variability was estimated by the
time rate index (the first derivative of SBP over time), standard deviation (SD) of 24-hour SBP; and coefficient of
variability of 24-hour SBP. ABI was measured with a doppler probe. The sample included 425 patients with a mean
age of 57 ± 12 years, being 69.2% women, 26.1% current smokers and 22.1% diabetics. Abnormal ABI (≤ 0.90 or
≥ 1.40) was present in 58 patients. The time rate index was 0.516 ± 0.146 mmHg/min in patients with abnormal
ABI versus 0.476 ± 0.124 mmHg/min in patients with normal ABI (P = 0.007). In a logistic regression model the
time rate index was associated with ABI, regardless of age (OR = 6.9, 95% CI = 1.1- 42.1; P = 0.04). In a multiple
linear regression model, adjusting for age, SBP and diabetes, the time rate index was strongly associated with ABI
(P < 0.01). None of the other indexes of BP variability were associated with ABI in univariate and multivariate
analyses.
Conclusion: Time rate index is a sensible method to measure BP variability by ABPM. Its performance for risk
stratification of patients with hypertension should be explored in longitudinal studies.
Background
The biomechanics of vascular damage induced by higher
blood pressure include circumferential, axial and shear
stresses [1]. In addition, blood pressure variation by
time (blood pressure variability) could play an additional
role in the development of endothelial dysfunction and
atherosclerosis [2,3]. This influence has been demon-
strated in experimental models [4]. The independent
association between higher blood pressure variability
and clinical outcomes has been also identified in clinical
[5,6] and epidemiological models [7,8]. The precise
assessment of blood pressure variability is only possible
with beat-to-beat BP recording [3,9], but the
development of non-invasive ambulatory blood pressure
monitoring (ABPM) opened the opportunity to estimate
blood pressure variability through various indexes
[7,8,10-13]
Despite the growing interest in using these parameters
for assessment of cardiovascular prognosis, it is still
unclear if they add substantial information over blood
pressure values and if there is superiority of any index
in this regard. Guidelines still do not recommend the
inclusion of measurements of blood pressure variability
on the report of ABPM examinations [14,15].
The ankle brachial index (ABI) has been considered a
marker of macrovascular atherosclerotic lesion [16-23],
and has been proposed to evaluate the integrity of
major arteries in high risk patients [24]. Values < 0.90
and ≥ 1.4 are associated with cardiovascular risk [24,25].
As far we know, the association between abnormal ABI
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and may be useful to explore the performance of various
indexes of blood pressure derived from ABPM. In this
report we present the association, in hypertensive
patients, between abnormalities in the ABI and three
indexes of blood pressure: the standard deviation (SD)
of mean BP [7,8], the coefficient of variability [6] and
time rate index [10].
Methods
This cross-sectional study was conducted in the Hyperten-
sion Clinic of the Division of Cardiology of Hospital de
Clínicas de Porto Alegre (Porto Alegre, Brazil). The study
was approved by the Ethics Committee of our Institution,
which is accredited by the Office of Human Research Pro-
tections as an Institutional Review Board, and all patients
signed a written informed consent for participation.
The study population was selected from a consecutive
sample of patients screened for participation in rando-
mized clinical trial of approaches to improve adherence
in patients with hypertension (MONITOR study/
NCT00921791). Patients were included in this analysis if
they had: [1] history of hypertension and were aged
between 18 to 80 years; [2] absence of history or clinical
evidence of severe complications related to hypertension
(coronary artery disease, heart failure, cerebrovascular
disease, end stage renal failure); [3] absence of clinical
suspicion or laboratory evidence of secondary hyperten-
sion; [4] agreed to participate in the study and had the
ability to provide the free and informed consent; [5]
possibility to perform ABI measurement (without ampu-
tation or ulcers of the lower limb).
Patients underwent to an extensive demographic and
clinical baseline data collection, including the assess-
ment of education, alcohol and tobacco consumption.
Patients with a history of angioplasty or coronary revas-
cularization, carotid endarterectomy, myocardial infarc-
tion, angina, heart failure, stroke, and transient ischemic
attack were considered as having cardiovascular disease.
The prevalence of peripheral arterial occlusive disease
(PAD) was defined as presence of intermittent claudica-
tion or angioplasty of lower limb vessels. Diabetes melli-
tus was defined as fasting plasma glucose ≥ 126 mg/dl
or use of antidiabetic drugs. BP was measured with an
office aneroid sphygmomanometer and the mean values
were estimated after an average of 6 measures in 3 dif-
ferent visits according to guidelines [26,27]. Patients
with BP within normal values but taking BP drugs and
those with severe hypertension (≥ 180/110 mmHg) or
evidence of clinical disease were classified on the occa-
sion of the first visit. Hypertension was defined as a
mean blood pressure ≥ 140/90 mm Hg or use of antihy-
pertensive medications. During the first visit ABI was
measured according to standard protocol [24] by trained
physicians using a device for Doppler ultrasound (Dop-
pler vascular laptop, model DV 610, with 10 MHz fre-
quency). A mercury manometer and appropriate cuffs
for measurement of brachial blood pressure and lower
limbs were used.
The ABI was defined as the ratio between the highest
systolic blood pressure of the ankle (posterior tibial or
dorsalis pedis arteries) and higher systolic pressure of
the arm (right or left) [24]. ABI was calculated for each
leg as the ratio between the average of two measures of
pressure on each limb. The cutoff point for diagnosis of
peripheral arterial disease (PAD) was ABI ≤ 0.90 or
≥ 1.40 [24,25].
All individuals were submitted to ABPM in a normal
working day (Spacelabs 90207, Spacelabs, Redmond,
WA). Readings were obtained at intervals of 15 minutes
during the day and 20 minutes on the night of 24 hours
throughout the period studied. Patients with less than 6
and 18 measures during the night and the day periods
respectively were excluded from further analysis [14].
Based on the results of ABPM, the mean 24-hour systo-
lic (SBP) and diastolic (DBP) blood pressures were cal-
culated for each patient. We calculated three different
parameters of systolic pressure variability: the standard
deviation of mean (SD), coefficient of variability (CV =
SD/mean pressure X100%) and rate of change in SBP
over time (mmHg/min) defined as the first derivative
values of SBP by time (time rate index). This index
allows the calculation of the sum of angular coefficients
and aims to measure how fast or how slow and which
direction SBP values change. The measure was calcu-
lated using the following formula [10]:
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Where r is the rate of BP variability over time (consid-
ering the differences between blood pressure measure-
ments in each time intervals) and N is the number of
recordings.
Statistical Analyses
The groups for comparison were defined by the pre-
sence or absence of an abnormal ABI: values ≤ 0.9 or
≥ 1.4 in any lower limb. Comparisons were tested by
Pearson’s chi-square test, unpaired Student t test, and
Mann-Whitney test. Logistic regression models and
multiple linear regression were used to evaluate the
association between parameters of variability of 24-hour
SBP and ABI. Age, 24-hour SBP and diabetes were
included in models. Three patients with ABI ≥ 1.4 in
any leg were not included in the multiple linear models.
All values are presented as mean and standard deviation,
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<0.05 were considered significant. The areas under
(AUC) the Receiver-operating characteristic curve
(ROC) of different 24-hour SPB variability indices were
calculated to compare the performance of these para-
meters in the prediction of abnormal ABI [28].
Data were analyzed using the program Statistical
Package for Social Science (SPSS version 14.0, Il, USA).
Results
A total of 482 patients were evaluated, being 57 excluded
because of lack of ABPM or ABI data, leading to the ana-
lysis of 425 patients (88% of those screened). The charac-
teristics of the sample are presented in Table 1.
Abnormal ankle-brachial index (ABI ≤ 0.90 and/or ≥ 1.4)
was detected in 58 patients (13.6%). Participants with
abnormal ABI were older, had higher 24-hour SBP and a
higher proportion of diabetics (Table 1). Among the
indexes of blood pressure variability, only the time rate
index was statistically different between the groups
(Table 1). Standard deviation and coefficient of variability
calculated separately for the daytime and nighttime peri-
ods were not associated with abnormal ABI also.
The independent association between the time rate
index and abnormal ABI was assessed by logistic regres-
sion models and multiple linear regression (considering
the right and left legs). The association was independent
of age (Table 2-model 1), but was lessened when 24-hour
SBP and diabetes were added to the model (Table 2-
model 2). With the exclusion of three individuals with
abnormal ABI because of higher values, the risk ratios
increased and were almost significant in the full model:
RR 18.7 (95% CI: 1.96-198.5; P = 0.01) when adjusted for
age and RR 10.7 (95% CI: 0.89-129.1; P = 0.06) when
adjusted for age, diabetes and 24-hour systolic blood
pressure. Models with the quadratic and cubic term of
the time-rate did not improve the intensity of association,
therefore excluding a relevant non-linear association. The
SD of 24-hour SBP and the CV were not associated with
abnormal ABI either in the model 1 (P = 0.46 for SD of
24-hour SBP and P = 0.90 for CV, respectively) or in the
second model (P = 0.70 for SD and P = 0.92 for CV,
Table 1 Distribution of selected characteristics in the whole sample and by the presence of an abnormal ABI
Total sample (n = 425) Abnormal ABI* (n = 58) Normal ABI (n = 367) P**
Age (years) 57.4 ± 12.1 63.6 ± 10.6 56.4 ± 12.0 <0.001
Male 131 (30.8%) 21 (36.2%) 110 (30%) 0.34
Body mass index (kg/m
2) 30.8 ± 5.8 29.7 ± 5.5 30.9 ± 5.9 0.12
White 280 (65.9%) 34 (58.6%) 246 (67%) 0.21
Alcohol abuse (> 30 g/day) 35 (8.2%) 6 (10.3%) 29 (7.9%) 0.53
Current Smoking 111 (26.1%) 16 (27.6%) 95 (25.9%) 0.44
(Years at school) 0.005
≤ 4 years 124 (29.2%) 26 (44.8%) 98 (26.7%)
> 4 years 301 (70.8%) 32 (55.2%) 269 (73.3%)
Diabetes mellitus 94 (22.1%) 20 (34.5%) 74 (20.2%) 0.01
Duration of hypertension (years) 0.01
≤ 10 years 212 (49,9%) 191 (53.5%) 21 (36.2%)
> 10 years 203 (47.8%) 166 (46.5%) 37 (63.8%)
Cardiovascular disease 119 (28%) 19 (32.8%) 100 (27.2%) 0.38
Office SBP (mmHg) 152.4 ± 25.9 156.9 ± 28.8 151.7 ± 25.5 0.16
Office DBP (mmHg) 88.7 ± 14.8 85.6 ± 14.7 89.2 ± 14.8 0.08
24-hour SBP (mmHg) 136.8 ± 17.3 141.0 ± 18.0 136.2 ± 17.1 0.04
24-hour DBP (mmHg) 80.9 ± 12.5. 78.8 ± 12.9 81.3 ± 12.5 0.13
Use of antihypertensive 316 (74.4%) 45 (77.6%) 271 (73.8%) 0.54
N° antihypertensive drugs (P25%-75%) 1 (1-1) 2 (1-3) 2 (0-3) 0.19
Time Rate SBP index (mmHg/min) 0.476 ± 0.124 0.516 ± 0.146 0.469 ± 0.119 0.007
SD SBP (mmHg) 12.7 ± 3.8 13.2 ± 4.7 12.6 ± 3.7 0.26
CV SBP (%) 9.3 ± 2.7 9.3 ± 2.6 9.3 ± 2.9 0.91
Table 2 Association of time rate index with abnormal ABI
in logistic regression models
Model 1 RR (95% CI) P
Time Rate (mmHg/min) 6.88 (1.12-42.15) 0.04
Age (years) 1.05 (1.02-1.07) <0.001
Model 2 RR (95% CI) P
Time Rate (mmHg/min) 5.84 (0.52-65.0) 0.15
Age (years) 1.05 (1.03-1.08) <0.001
24-hour SBP (mmHg) 1.01 (0.99-1.03) 0.41
Diabetes mellitus 1.71 (0.92-3.18) 0.09
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minimum ABI showed no association with any of the
variables examined, possibly due to a restricted range of
response. However, the time-rate index was associated
with the ABI separately in the right and left legs, and
with the mean ABI for the patient (table 3), adjusting for
age, diabetes and 24-hour SBP. The introduction of 24-
ABPM pulse pressure in the models instead of systolic
blood pressure did not change the independent associa-
tion between the time rate index and ABI. SD of 24-hour
SBP and the coefficient of variability were not associated
with ABI in this model (P higher than 0.05 for both
indexes and both legs).
Table 4 shows that only the time-rate index had statis-
tically significant AUC values to predict abnormal ABI.
The best cut-off point of the time-rate index to predict
abnormal ABI was 0.478 mmHg/min. Adding the time-
rate index to a model with systolic and diastolic blood
pressure the C-index increased from 0.637 (95% CI
0.559 to 0.714) to 0.648 (95% CI 0.575 to 0.722).
Discussion
In this large sample of patients with hypertension
screened for a randomized clinical trial we identified
that nearly 14% of participants had an abnormal ABI.
This prevalence is similar to that reported in
population-based studies [16,17,19-21] but lower than
the described in a secondary analysis of a randomized
clinical trial [18]. Differences in the sample characteris-
tics explain the variable prevalence of abnormalities in
the ABI that has been reported in different studies. In
the present study all participants had hypertension and
almost a quarter had diabetes.
Individuals with abnormal ABI had higher blood pres-
sure variability only if measured by the time rate index.
This association was robust and independent of age
when ABI was stratified in normal and abnormal. Systo-
lic blood pressure and diabetes lowered the intensity of
this association. On the other hand, when ABI was
included as a dependent variable in a linear model,
there was a strong and independent association with BP
variability exclusively measured by the time rate index.
In this regard, our findings are in agreement with those
reported by Zakopoulos and colleagues, who demon-
strated, in a cross-sectional study with 539 individuals,
that only the time rate index was independently asso-
ciated with the thickness of the carotid artery measured
by ultrasound [10]. Our findings confirm that this asso-
ciation is independent of blood pressure levels. We had
previously shown, in a secondary analysis of a rando-
mized clinical trial [29], that the time-rate index was
independent even from blood pressures changes induced
by drug treatment [30].
Abnormal ABI has been identified as a marker of vas-
cular damage by atherosclerosis [24]. Values ≤ 0.90 at
rest are recognized as the cutoff for diagnosis of PAD
[24] but values ≥ 1.4 are also associated with athero-
sclerotic disease and PAD [24,25]. Beside, it has been
recognized as an independent marker of cardiovascular
risk [16-23]. Various longitudinal studies have demon-
strated that the severity of PAD in the lower limbs corre-
lates with the risk of acute myocardial infarction, stroke
and death from vascular causes [17-23]. Thus, the ABI is
a good marker of atherosclerosis and due to its easy
implementation it is increasingly being used in the daily
practice for risk stratification of hypertensive patients.
The cross-sectional nature of our investigation pre-
cludes establishing temporal causality. Abnormal BP
pressure variability could be responsible for the develop-
ment of vascular abnormalities as well the vascular
rigidity could lead to higher blood pressure variability.
Longitudinal studies should be launched to identify if
abnormalities in BP pressure variability precede the vas-
cular damage detected by ABI. In face of the risks iden-
tified in cohort studies, with other indexes of blood
pressure variability, it is expected that abnormalities in
the ABI are favored by higher blood pressure variability.
These findings can be explained by the association
between the process of atherosclerosis and the hemody-
namic changes that lead to vascular endothelial injury.
Table 3 Association between the time-rate index and ABI
in multiple linear regression model
Beta S.E. P
Right lower limb
Time Rate SBP (mmHg/min) -0.15 0.06 0.003
24-hour SBP (mmHg) -0.09 < 0.001 0.09
Age (years) -0.11 0.001 0.02
Diabetes Mellitus -0.02 0.15 0.62
Left leg limb
Time Rate SBP (mmHg/min) -0.13 0.05 0.01
24-hour SBP (mmHg) -0.05 < 0.001 0.28
Age (years) -0.12 < 0.001 0.01
Diabetes mellitus -0.01 0.01 0.82
Mean of both legs
Time Rate SBP (mmHg/min) -0.14 0.05 0.005
24-hour SBP (mmHg) -0.08 < 0.001 0.11
Age (years) -0.12 < 0.001 0.009
Diabetes mellitus -0.004 0.01 0.77
Table 4 Area under the curve (AUC) of the different
measurements of variability to predict an abnormal ABI
AUC CI 95% P
CV SBP 0.52 0.43 - 0.60 0.70
SD SBP 0.53 0,44 - 0,61 0.48
Time Rate SBP 0.60 0.51 - 0.68 0.02
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strated that the phenotype of endothelial injury is
directly linked to the changes in blood flow [31]. Ather-
osclerotic plaques with a vulnerable aspect were present
mainly in areas of low shear stress, while in areas of tur-
bulent flow (or vortices) the plaques seemed stable.
Interpreting these findings, Richter and Edelman stated
that rather than the absolute shear stress value (higher
or lower), it is the variations in blood flow that could
modify the endothelial biology [32]. Therefore, para-
meters of pressure variation could be related to the risk
of damage to a target organ in hypertension. Such find-
ings have been demonstrated in studies using invasive
measurement of blood pressure [2-5], but the challenge
to incorporate the measurement of variability in daily
clinical practice still remains.
Despite that the precise assessment of blood pressure
variability is only possible with beat-to-beat BP record-
ing [33], our findings expand the possibility to measure
blood pressure variability by ABPM, confirming the
findings of Zakopoulos et. al [10]. Different parameters
of BP variability derived from ABPM have been
described [11-13], but the time-rate index embodies the
concept that in the analysis of blood pressure variability
it is important to measure not only blood pressure dif-
ferences between each measure but how fast or how
slow it occurs and to which direction the blood pressure
changes. Our results indicate that the time rate index
m a yb em o r ep o w e r f u lt oe s t i m a t et h et r u ev a r i a b i l i t y
than standard deviation from the mean and coefficient
of variability. It was the only index associated with con-
tinuous and abnormal values of ABI. It was, also, the
only index to have statistically significant AUC to
explain about 60% of the occurrence of an abnormal
ABI in this sample. It was previously demonstrated that
blood pressure variability evaluated by the standard
deviation and coefficient of variability using blood pres-
sure of the nighttime period has a more intense associa-
tion with cardiovascular outcomes [8,34]. This
association was not evident in our study, but this may
be potentially ascribed to statistical power. In a recent
report from a large population cohort, BP variability
assessed by standard deviation did not contribute for
risk stratification beyond 24-hour BP [35]. The time-rate
index may perform better, and should be also investi-
gated in large cohort studies, including its capacity to
increase the precision of prognostic estimation.
Conclusions
In conclusion, variability of systolic blood pressure over
time derived from ABPM- the time rate index is asso-
ciated with the ankle-brachial index. Blood pressure
variability measured by the standard deviation of 24-
hour SBP and by the coefficient of variability are not
associated with the ankle-brachial index. The perfor-
mance of the time rate index to identify cardiovascular
risk over blood pressure values should be explored in
longitudinal studies.
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